Skip to main content

Topic

FDA Approval

198 published works

  1. Healthcare Law Insights

    FDA Complete Response Letters: The design v. reality of FDA’s responses to drug applications

    By Diane Romza-Kutz, Fredric Roth V

    Recent trends in the U.S. Food and Drug Administration's ("FDA’s") utilization of Complete Response Letters (“CRLs”) would indicate there may be a disconnect between the intended use of CRLs and…

  2. Health Law Prof Blog

    Guest Blogger Associate Dean and Professor of Law Joan H. Krause: The Right to Try Meets the Reality of Drug Approval

    By Katharine Van Tassel

    Whether it be a social media campaign to convince a company to provide an experimental anti-viral drug to a young cancer patient suffering from a life-threatening infection or the debate…

  3. Animal Law Update

    Recognizing the Vital Contributions of Animals to Biomedical Research

    By Nancy E. Halpern, D.V.M.

    There are a lot of myths circulated by animal rights activists about the use of animals in biomedical research, which they are opposed to, even when such research benefits the…

  4. GlobalTort

    The Pace of Science and Business – More Speed

    By Kirk Hartley

    Velocity continues to increase for turning cutting edge molecular biology into businesses and new treatments. On March 14, the UK announced fast advancing plans to emulate the US FDA's approach…

  5. Dangerous Drugs & Medical Devices

    FDA won’t say which drugs on the market were approved based on fraudulent research

    By Justinian Lane

    This shows that the FDA is more interested in protecting pharmaceutical companies than patients.  Note how Woodcock doesn’t want to force new trials because that requires human experimentation, which has…

  6. Focus on Regulation

    New FDA Draft Guidance on Dispute Resolution: An Important Appeal Pathway for Drug Companies

    By Robert Church, Bert Lao

    On March 13, 2013, FDA announced in the Federal Register the availability of an FDA draft guidance, titled “Formal Dispute Resolution: Appeals Above the Division Level.”  Formal dispute resolution affords…

  7. Drug & Device Law

    Hail! Hail! To Michigan

    By Bexis

    Here's another guest post this time by Clem C. Trischler and Jason M. Reefer, of Pietragallo Gordon, about a recent litigation involving the Michigan immunity statute and when a "drug"…

  8. DuetsBlog

    FDA Trademark Approval

    By Duets Guest Blogger

    --Susan Perera, Attorney One aspect of trademark law that we haven’t discussed here at DuetsBlog is FDA approval of trademarks for pharmaceuticals.  While there are certainly many benefits to federal…

  9. Reproductive Rights Prof Blog

    Stem-Cell-Based Drug Approved in Canada for Treatment of Graft-Versus-Host Disease

    By Reproductive Rights

    The New York Times: A Stem-Cell-Based Drug Gets Approval in Canada, by Andrew Pollack:In a boost for the field of regenerative medicine, a small biotechnology company has received regulatory approval in…

  10. Supreme Court Update

    Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S (10-844), Mohamad v. Palestinian Authority (11-88) and Order List

    By Kim Rinehart

    The unanimous decisions continued last week with Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S (10-844), holding that a generic drug manufacturer may bring a counterclaim against a brand-name drug…